The study of recessive oncogenes such as those responsible for retinoblastoma and Wilms tumor is difficult because the gene products involved are unknown and because the diseases are not associated with unique cellular or molecular phenotypes suitable for genetic manipulation. Since the gene for esterase D (ESD) is known to be tightly linked to the retinoblastoma locus (RBI) in the q14.1 band of chromosome 13, we have cloned the ESD gene from a human cDNA library by using oligonucleotides specific for a partial amino acid sequence of the purified enzyme to provide a genetic marker for further studies on retinoblastoma. The putative ESD gene codes for a message of 1.2 kilobases, which is present in all cell types examined, and maps to 13ql4.1, thus confirming that it is the ESD gene. Restriction enzyme analysis reveals a restriction fragment length polymorphism with Apa I; this polymorphism results from the heterozygosity of 32% of the individuals tested and is shown to be useful in identifying carriers of the mutation responsible for retinoblastoma. A preliminary screen of 24 retinoblastoma tumors by Southern blot did not reveal any homologous deletions or rearrangements of the ESD locus.
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The recessive oncogenes that initiate certain childhood tumors (1-3) may normally regulate the expression of other genes during development (4) . Failure of the regulating gene to function normally may allow the inappropriate expression of other genes, perhaps traditional oncogenes, leading to the development of a malignant state. Because of their importance in initiation of cancer, and their probable role in normal regulation, it would be of great interest to identify these recessive oncogenes and to characterize their products.
One such recessive mutation that has been well characterized is retinoblastoma, at the genetic locus RBI. Since an experimental assay for the gene product of the RBI locus is not available, a cloned closely linked marker would provide a means to approach the retinoblastoma gene. Although other genes have been provisionally assigned to chromosome 13 (5, 6) , the gene for esterase D ESD is the only one proven to be tightly linked to retinoblastoma (7, 8) . Among informative families (extensively studied families of patients with retinoblastoma), there are no reported genetic recombinations between the ESD and RBI loci (9) . The only separation of the two loci is defined by a gross chromosome abnormality involving a deletion beginning in the q14 band and extending distally to q22 (10) . Since this deletion affects the RBI locus and not the ESD locus, the ESD gene must lie closer to the centromere than RB). In a careful prophase banding analysis of several patients with deletions, Ward et al. (8) regionally mapped the ESD and RB) loci in the upper half of the q14. 11 subband of chromosome 13. Since each prophase band contains approximately 3000 kilobases (kb) of DNA, these two loci must be separated by less than this distance. It is unclear where other DNA markers mapped to the q14 region (11, 12) are located relative to the RBJ and ESD loci. To obtain a close molecular probe to RBJ for use in "chromosomal walking" experiments, we undertook the molecular cloning of the ESD gene.
MATERIALS AND METHODS
Esterase D Protein Purification. Packed erythrocytes (14 liters) were used to obtain 4 mg of pure esterase D (13) . Because the amino terminus was blocked, an amino acid sequence of 25 residues was obtained from the largest cyanogen bromide cleavage peptide fragment CN3 using an Edman sequenator followed by HPLC. The sequence was obtained using a Beckman Model 890C sequencer.
Oligonucleotide Screening of DNA Library. Two oligonucleotides, a 20-mer and a 17-mer, were chosen as probes based on the amino acid sequence of CN3. Because cyanogen bromide cleavage occurs at the carboxyl side of methionine residues, we also included an AUG in one oligonucleotide. from rapid plasmid preparations using alkaline lysis (15) followed by Southern blotting and oligonucleotide hybridization.
DNA Sequencing. All sequencing was done by the Sanger dideoxy chain-termination method (16) . The 3' BamHI restriction fragment of pESD-14.1.1, which was positive for both oligonucleotides, was inserted into pEMBL (17) and sequenced in both directions, using the M13 single-stranded primer and unidirectional digestion with exonuclease III to generate targeted deletions in the cloned DNA segment (18) . The 117-nucleotide fragment on the 3' side of the internal BamHI recognition site of pESD-14.1.1 was sequenced and found to contain a complete open reading frame of 39 amino acids.
Cell Lines and Retinoblastoma Tumors. The fibroblasts AG 1142 and AG 2718 were obtained from the Human Genetic Mutant Cell Repository (19) . The lymphoblastoid line of the patient EL was generously provided by Hans Ochs. Retinoblastoma tumors were surgically removed from patients and grown as xenografts in nude mice and in tissue culture. The panel of somatic cell hybrids used for mapping the ESD gene has been described in detail elsewhere (20, 21) .
Blot Hybridization. DNA was extracted from 0.5 to 1.0 x 108 fibroblasts, lymphoblastoid lines, or retinoblastoma tumors by the standard method of phenol and isoamyl alcohol extraction followed by ethanol precipitation (22) . Samples of DNA were digested with restriction enzymes (Boehringer Mannheim) using conditions recommended by the supplier. Digested genomic DNA was separated by gel electrophoresis in 1.0% agarose, and blotted onto nitrocellulose membranes (23) . DNA probes were radiolabeled with [32P]dCTP by nick-translation (24) to a specific activity of 3 x 108 cpm/,Ug.
Filters were washed under high stringency conditions (0.1 x A SSC/0.2% NaDoSO4, 650C). Autoradiography was carried out overnight at -70°C using one or two intensifying screens. Probes were stripped with water at 60°C for 30 min. DNA hybridization ratios were estimated by band grain density on autoradiograms using a Bio-Rad 620 Video Densitometer and Bio-Rad Model 3392A Integrator.
DNA Probes. The ESD probe refers to the pESD-14.1.1 Xho I fragment; MYC probe refers to the pHSR 9-kb EcoRI-HindIII fragment (25) ; the T-cell receptor (TCR) probe refers to the pYT35 Ava I-EcoRV fragment (26) .
RESULTS
Isolation of Esterase D cDNA Clone. Because of its widespread use as a polymorphic genetic marker, esterase D has been studied in many laboratories, and a purification scheme for this enzyme has been described by Scott and Wright (13) . Applying their protocol to human erythrocytes, we obtained 4 mg Qf enzyme, which was homogeneous by gel electrophoresis. The monomer molecular size of the purified enzyme was 33 kDa; the active form of the enzyme is a dimer. Although the amino terminus was blocked, we obtained a partial amino acid sequence from a large, 11-kDa, cyanogen bromide fragment (CN3). A sequence of 25 Genetics: Squire et al.
-mer, only 4 also hybridized with the 17-mer. Analysis ofthese 4 clones revealed that they had the same restriction map and were homologous to each other on Southern blots. The clone with the largest insert (1.2 kb), pESD-14.1.1, was selected for further analysis. The DNA sequence was determined for that region of the clone containing the sequences hybridizing to the oligonucleotides. Fig. 1A shows
To establish unequivocally that the isolated gene was ESD, it was mapped to chromosome 13 by four different techniques. (i) The pESD-14.1.1 probe hybridized to identical HindIll restriction fragments in blots of total human DNA and in DNA isolated from a sorted chromosome 13 library (11) (data not shown).
(ii) The presence of the gene was examined in 25 mouse-human hybrids (20, 21) . There was no discordance in the association of the presence of the isolated clone and the presence of chromosome 13; all other chromosomes showed discordancies in five or more hybrids (data not shown). In addition, there was complete concordance in these hybrids between the presence of ESD DNA and the presence of the gene for human propionyl-CoA carboxylase (a chain), which has been independently assigned to chromosome 13 (21) . If there are multiple copies of the ESD gene or pseudogenes, they must also be on chromosome 13.
(iii) The probe was tested for linkage to the retinoblastoma locus using families with hereditary retinoblastoma. A total of 35 individuals were studied, and the probe detected a polymorphic Apa I recognition site with two codominant allelic restriction fragments of 8.6 and 7.2 kb (Fig. 2) . This restriction fragment length polymorphism must be distinct from the allelic isozymes of ESD detected by starch gel electrophoresis (27) and confirm the assignment of these DNA sequences to chromosome 13.
(iv) We studied by quantitative hybridization the pESD-14.1.1 sequences in cell lines containing different deletions of chromosome 13. As shown in Fig. 3 , two copies of pESD-14.1.1 are present in normal control fibroblasts and in the lymphoblastoid cells from patient EL who has a known deletion in chromosome 13 beginning between the ESD and RBI loci (10) . ESD is present in single copy in two lines, AG1142 (29) and AG2718 (37); both lines have known deletions involving most of the q14 region affecting both the ESD and RB) loci. The lymphoblastoid cells from patient number RB449, who has a deletion distal to band 13q14 and who does not have retinoblastoma, also have two copies of the ESD gene (data not shown). The line AG1142 is particularly interesting because its deletion is shorter than the EL deletion and appears cytogenetically to begin at the same place as the EL deletion. As shown in Fig. 3 Since the ESD locus is very close to the RBJ locus, one might expect the ESD gene to be affected by some of the somatic mutations known to be associated with the RB1 locus in all retinoblastoma tumors. Indeed, Benedict et al. (30) have suggested that one of their patients has a submicroscopic deletion affecting both loci; the retinoblastoma tumor that developed was monosomic, lacked ESD activity, and apparently retained only the deleted chromosome 13. In addition, Cowell et al. (31) reported several patients with half-normal levels ofesterase D activity in their erythrocytes, again suggesting the possibility of microdeletion in q14.1 affecting both ESD and RB). Ifmutations at the RBI locus are similar to mutations at other loci, approximately 10% may involve deletions (32) , some of which may be quite large and include the ESD locus. Fig. 4 shows a Southern blot of DNA from 11 retinoblastoma tumors. As shown in this figure, none of these tumors has a homozygous deletion or alteration for any of the five major hybridizing fragments detected in a HindIII digest. A total of 24 tumors have been examined using HindIII, and all showed an apparently normal germ-line configuration. However, it is important to note that a small percentage of tumors could have ESD present in a hemizygous state. Using standard techniques, only bands associated with deletion or rearrangement would be detectable; attempts to look for tumors with simple deletions resulting in single copy ESD would require a detailed analysis by quantitative hybridization.
DISCUSSION
Development of retinoblastoma almost certainly requires mutations in both alleles at the RBI locus (1, 2) . In approximately 70% of retinoblastoma tumors, somatic chromosome changes lead to homozygosity of all markers on chromosome 13, resulting in homozygous mutations at RB). Homozygous deletions beyond a certain size will be cellular lethals because they will delete other essential genes closely linked to the RBI locus. In support of this suggestion, patients with large, karyotypically detectable, germ-line deletions have fewer tumors than patients with a normal karyotype (33) . It has been suggested that patients with congenital deletions are not susceptible to the most common somatic events that generate homozygosity (2, 34 deletions affecting ESD and RBJ may be lethal. On the basis of our failure to detect homozygous deletions in 24 tumors, the possibility that the patient reported by Benedict et al. (30) represents two independent mutations, one in RB) and one in ESD, rather than a single deletion affecting both loci must be considered.
The natural substrate for esterase D is O-acetylated sialic acid, and a metabolic role for the enzyme has been postulated in the reutilization of sialic acids (35) . Conservation and ubiquitous expression of the ESD gene suggests an important normal function. We have found esterase D to be expressed in all cell types tested and to be highly conserved. At high stringency hybridization, Pst I-digested DNA had a similar restriction pattern in both rodents and human DNA, and only one major band differed between HindIII and EcoRI digests. This stability is consistent with the wide tissue distribution found for the O-acetyl esterase, supporting the proposed identification of Varki et al. (35) .
ESD is the fourth DNA fragment mapped to the q14 band on chromosome 13. The others are random DNA fragments, p7D2 (12), H2-42 (11), and H3-8 (11) . The precise order of these markers in relation to each other and to ESD and RBI is unknown. We found two copies of the H3-8 sequence present in EL fibroblasts (data not shown). Thus, this probe, like ESD, is proximal to the RBI locus, but its relation to ESD is unknown. As with the ESD probe, no abnormalities were observed in the H3-8 sequence in the 24 tumors studied. We have not examined the hybridization of H2-42 and p7D2 with our panel of tumors.
On the basis of published results and the data presented here, it is only possible to give a crude estimate of the separation of the ESD and RB) loci. Our preliminary results suggest that ESD is more than 5 kb from the RBI locus; otherwise we should have detected abnormalities in the ESD gene in some of the tumors examined. As described above, Ward et al. (8) have placed the ESD and RBI loci in the top half of the small chromosome subband 13q14.11, a region encompassing at most 3000 kb. Thus, we estimate that ESD and RBI are separated by more than 5 kb and less than 1500 kb. As ESD is the only well-characterized genetic marker in the immediate vicinity of RBI, the cDNA probe spanning more than 30 kb of this genomic region will provide an ideal starting place for chromosomal walking experiments. Fur- B thermore, the availability of the EL deletion will allow orientation with respect to the centromere in initial steps of the walk. Application ofthe techniques for manipulating large fragments of DNA (36) should allow ordering ofESD and the other DNA fragments on chromosome 13 and an estimation of the distances between the markers and the breakpoints of various deletions associated with retinoblastoma. The ESD probe will be immediately useful for improved genetic counseling for patients with retinoblastoma because of the much larger numbers of heterozygotes now detectable using the Apa I polymorphism.
